Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

MicroRNAs as novel immunotherapeutics.

Heimberger AB, Gilbert M, Rao G, Wei J.

Oncoimmunology. 2013 Aug 1;2(8):e25124. Epub 2013 May 28.

2.

miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.

Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB.

Cancer Res. 2013 Jul 1;73(13):3913-26. doi: 10.1158/0008-5472.CAN-12-4318. Epub 2013 May 1.

3.

Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.

Butt AQ, Mills KH.

Oncogene. 2014 Sep 18;33(38):4623-31. doi: 10.1038/onc.2013.432. Epub 2013 Oct 21. Review.

PMID:
24141774
4.

Hypoxia potentiates glioma-mediated immunosuppression.

Wei J, Wu A, Kong LY, Wang Y, Fuller G, Fokt I, Melillo G, Priebe W, Heimberger AB.

PLoS One. 2011 Jan 20;6(1):e16195. doi: 10.1371/journal.pone.0016195.

5.

Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.

Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK, Gumin J, Henry V, Colman H, Priebe W, Sawaya R, Lang FF, Heimberger AB.

Mol Cancer Ther. 2010 Jan;9(1):67-78. doi: 10.1158/1535-7163.MCT-09-0734. Epub 2010 Jan 6.

6.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
7.

MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide.

Zhang S, Wan Y, Pan T, Gu X, Qian C, Sun G, Sun L, Xiang Y, Wang Z, Shi L.

J Mol Neurosci. 2012 Jun;47(2):346-56. doi: 10.1007/s12031-012-9759-8. Epub 2012 Apr 19.

PMID:
22528454
8.

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG.

BMC Med. 2008 Jun 24;6:14. doi: 10.1186/1741-7015-6-14.

9.

The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.

Gao X, Jin W.

Cancer Lett. 2014 Oct 10;353(1):25-31. doi: 10.1016/j.canlet.2014.07.011. Epub 2014 Jul 17. Review.

PMID:
25042866
10.

The role of microRNAs in breast cancer stem cells.

Schwarzenbacher D, Balic M, Pichler M.

Int J Mol Sci. 2013 Jul 15;14(7):14712-23. doi: 10.3390/ijms140714712. Review.

11.

Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger AB.

Clin Cancer Res. 2010 Dec 1;16(23):5722-33. doi: 10.1158/1078-0432.CCR-10-1693. Epub 2010 Oct 4.

12.

Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.

Nikaki A, Piperi C, Papavassiliou AG.

Expert Opin Investig Drugs. 2012 Oct;21(10):1475-88. Epub 2012 Jul 19. Review.

PMID:
22809292
13.

Glioblastoma multiforme stem cells.

Dimov I, Tasić-Dimov D, Conić I, Stefanovic V.

ScientificWorldJournal. 2011 Apr 19;11:930-58. doi: 10.1100/tsw.2011.42. Review.

14.

Interplay between microRNAs and the STAT3 signaling pathway in human cancers.

Cao Q, Li YY, He WF, Zhang ZZ, Zhou Q, Liu X, Shen Y, Huang TT.

Physiol Genomics. 2013 Dec 15;45(24):1206-14. doi: 10.1152/physiolgenomics.00122.2013. Epub 2013 Nov 5. Review.

15.

MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.

Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CM.

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5316-21. doi: 10.1073/pnas.1202465109. Epub 2012 Mar 19.

16.

MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme.

González-Gómez P, Sánchez P, Mira H.

Mol Neurobiol. 2011 Dec;44(3):235-49. doi: 10.1007/s12035-011-8196-y. Epub 2011 Jul 5. Review.

PMID:
21728042
17.

MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.

Shi L, Zhang S, Feng K, Wu F, Wan Y, Wang Z, Zhang J, Wang Y, Yan W, Fu Z, You Y.

Int J Oncol. 2012 Jan;40(1):119-29. doi: 10.3892/ijo.2011.1179. Epub 2011 Aug 29.

PMID:
21879257
18.

Roles of miRNAs in regulating the differentiation and maturation of myeloid-derived suppressor cells.

Tian J, Rui K, Wang S.

Med Hypotheses. 2014 Aug;83(2):151-3. doi: 10.1016/j.mehy.2014.05.006. Epub 2014 May 20.

PMID:
24916610
19.

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.

Jordan JT, Sun W, Hussain SF, DeAngulo G, Prabhu SS, Heimberger AB.

Cancer Immunol Immunother. 2008 Jan;57(1):123-31. Epub 2007 May 24. Erratum in: Cancer Immunol Immunother. 2008 Jan;57(1):133.

PMID:
17522861
20.

microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells.

Tezcan G, Tunca B, Bekar A, Preusser M, Berghoff AS, Egeli U, Cecener G, Ricken G, Budak F, Taskapılıoglu MO, Kocaeli H, Tolunay S.

Cell Mol Neurobiol. 2014 Jul;34(5):679-92. doi: 10.1007/s10571-014-0050-0. Epub 2014 Apr 2.

PMID:
24691539
Items per page

Supplemental Content

Write to the Help Desk